Practice Areas

Five disciplines, senior-level execution.

Grounded in over 15 years of cross-functional expertise, delivered without the overhead of a large enterprise firm.

FDA 510(k) 21 CFR 807 EU MDR 2017/745 Q-SUB

Regulatory Strategy & Global Submissions

End-to-end pre-market and post-market strategy, scoped to get a product to market on the fastest defensible pathway, and keep it there.

  • • FDA 510(k) traditional and special submissions
  • • Premarket Approval (PMA) strategy and modular review planning
  • • De Novo classification requests
  • • Pre-Submission (Q-Sub) strategy and FDA briefing packages
  • • EU MDR Technical Documentation alignment (Annex II/III)
  • • Sequencing global market access across US and EU jurisdictions
FORM 483 WARNING LETTER 21 CFR 820.100

Crisis Management & Remediation

Executive-level leadership when the stakes are highest: engaged directly, without layers of account management standing between you and the work.

  • • FDA Form 483 response strategy and drafting
  • • Warning Letter remediation planning and execution
  • • CAPA program overhauls, root cause through effectiveness checks
  • • Systemic compliance recovery for consent-decree environments
21 CFR 820 / QSMR ISO 13485:2016 MDSAP ISO 19011:2018

Quality Management Systems & Auditing

Comprehensive QMS design, overhaul, and auditing, led by an ISO 13485:2016 Lead Auditor (TPECS certified).

  • • QMS design and overhaul under 21 CFR 820 (QMSR) and ISO 13485
  • • MDSAP program readiness
  • • Internal and external audit leadership, including mock audits
  • • Health authority inspection readiness
21 CFR 820.30 ISO 14971 DHF

Design Controls & Verification/Validation

Technical writing and engineering governance for the files that regulators, notified bodies, and your own future audits will hold you to.

  • • Design history file (DHF) construction and remediation
  • • Risk management files per ISO 14971
  • • Verification/validation protocol authoring and execution oversight
  • • Cross-functional engineering governance
21 CFR 820.30(i) CHANGE CONTROL

Change Control & Lifecycle Governance

Knowing whether a modification is a documentation update or a new submission is the difference between a controlled change and an inspection finding.

  • • Strategic impact assessments for proposed changes
  • • Design change evaluations across hardware, software, and materials
  • • Regulatory gap analyses ahead of implementation
  • • Change control board advisory

Not sure which of these you need first?

Most engagements start with a diagnostic conversation, not a proposal. Bring the situation as it stands.